Credit Suisse Ag Adamas Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
N/A
-20,995 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
N/A
20,995 New
20,995 $107,000
Q2 2019

Aug 14, 2019
SELL
N/A
-21,149 Closed
0 $0
Q1 2019

May 14, 2019
BUY
N/A
2,353 Added 12.52%
21,149 $151,000
Q4 2018

Feb 13, 2019
BUY
N/A
2,001 Added 11.91%
18,796 $161,000
Q3 2018

Nov 13, 2018
SELL
N/A
-18,712 Reduced 52.7%
16,795 $337,000
Q2 2018

Aug 14, 2018
BUY
N/A
8,764 Added 32.77%
35,507 $917,000
Q1 2018

May 15, 2018
BUY
N/A
1,408 Added 5.56%
26,743 $640,000
Q4 2017

Feb 14, 2018
SELL
N/A
-7,543 Reduced 22.94%
25,335 $859,000
Q3 2017

Nov 14, 2017
BUY
N/A
32,878
32,878 $697,000

About Adamas Pharmaceuticals, Inc.

ADMS Quotes by TradingView
  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email